415 related articles for article (PubMed ID: 17224156)
1. Pregnancy-associated malaria: parasite binding, natural immunity and vaccine development.
Gamain B; Smith JD; Viebig NK; Gysin J; Scherf A
Int J Parasitol; 2007 Mar; 37(3-4):273-83. PubMed ID: 17224156
[TBL] [Abstract][Full Text] [Related]
2. Antibodies from malaria-exposed pregnant women recognize trypsin resistant epitopes on the surface of Plasmodium falciparum-infected erythrocytes selected for adhesion to chondroitin sulphate A.
Sharling L; Enevold A; Sowa KM; Staalsoe T; Arnot DE
Malar J; 2004 Sep; 3():31. PubMed ID: 15350207
[TBL] [Abstract][Full Text] [Related]
3. Plasmodium falciparum: VAR2CSA expressed during pregnancy-associated malaria is partially resistant to proteolytic cleavage by trypsin.
Nielsen MA; Resende M; Alifrangis M; Turner L; Hviid L; Theander TG; Salanti A
Exp Parasitol; 2007 Sep; 117(1):1-8. PubMed ID: 17442305
[TBL] [Abstract][Full Text] [Related]
4. VAR2CSA and protective immunity against pregnancy-associated Plasmodium falciparum malaria.
Hviid L; Salanti A
Parasitology; 2007; 134(Pt 13):1871-6. PubMed ID: 17958922
[TBL] [Abstract][Full Text] [Related]
5. Maternal malaria: Plasmodium falciparum sequestration in the placenta.
Andrews KT; Lanzer M
Parasitol Res; 2002 Aug; 88(8):715-23. PubMed ID: 12122428
[TBL] [Abstract][Full Text] [Related]
6. Placental chondroitin sulfate A-binding malarial isolates evade innate phagocytic clearance.
Serghides L; Patel SN; Ayi K; Kain KC
J Infect Dis; 2006 Jul; 194(1):133-9. PubMed ID: 16741892
[TBL] [Abstract][Full Text] [Related]
7. VAR2CSA is the principal ligand for chondroitin sulfate A in two allogeneic isolates of Plasmodium falciparum.
Duffy MF; Maier AG; Byrne TJ; Marty AJ; Elliott SR; O'Neill MT; Payne PD; Rogerson SJ; Cowman AF; Crabb BS; Brown GV
Mol Biochem Parasitol; 2006 Aug; 148(2):117-24. PubMed ID: 16631964
[TBL] [Abstract][Full Text] [Related]
8. Analysis of IgG with specificity for variant surface antigens expressed by placental Plasmodium falciparum isolates.
Khattab A; Reinhardt C; Staalsoe T; Fievet N; Kremsner PG; Deloron P; Hviid L; Klinkert MQ
Malar J; 2004 Jul; 3():21. PubMed ID: 15242514
[TBL] [Abstract][Full Text] [Related]
9. Nonimmune immunoglobulin binding and multiple adhesion characterize Plasmodium falciparum-infected erythrocytes of placental origin.
Rasti N; Namusoke F; Chêne A; Chen Q; Staalsoe T; Klinkert MQ; Mirembe F; Kironde F; Wahlgren M
Proc Natl Acad Sci U S A; 2006 Sep; 103(37):13795-800. PubMed ID: 16945914
[TBL] [Abstract][Full Text] [Related]
10. The immuno-epidemiology of pregnancy-associated Plasmodium falciparum malaria: a variant surface antigen-specific perspective.
Hviid L
Parasite Immunol; 2004; 26(11-12):477-86. PubMed ID: 15771683
[TBL] [Abstract][Full Text] [Related]
11. Variant surface antigen-specific IgG and protection against clinical consequences of pregnancy-associated Plasmodium falciparum malaria.
Staalsoe T; Shulman CE; Bulmer JN; Kawuondo K; Marsh K; Hviid L
Lancet; 2004 Jan; 363(9405):283-9. PubMed ID: 14751701
[TBL] [Abstract][Full Text] [Related]
12. Acquisition and decay of antibodies to pregnancy-associated variant antigens on the surface of Plasmodium falciparum-infected erythrocytes that protect against placental parasitemia.
Staalsoe T; Megnekou R; Fievét N; Ricke CH; Zornig HD; Leke R; Taylor DW; Deloron P; Hviid L
J Infect Dis; 2001 Sep; 184(5):618-26. PubMed ID: 11494167
[TBL] [Abstract][Full Text] [Related]
13. Malaria blood-stage infection and its control by the immune system.
Perlmann P; Troye-Blomberg M
Folia Biol (Praha); 2000; 46(6):210-8. PubMed ID: 11140853
[TBL] [Abstract][Full Text] [Related]
14. Role of nonimmune IgG bound to PfEMP1 in placental malaria.
Flick K; Scholander C; Chen Q; Fernandez V; Pouvelle B; Gysin J; Wahlgren M
Science; 2001 Sep; 293(5537):2098-100. PubMed ID: 11557894
[TBL] [Abstract][Full Text] [Related]
15. Biomedicine. Turncoat antibodies.
Duffy PE; Fried M
Science; 2001 Sep; 293(5537):2009-10. PubMed ID: 11557864
[No Abstract] [Full Text] [Related]
16. Progress and Insights Toward an Effective Placental Malaria Vaccine.
Gamain B; Chêne A; Viebig NK; Tuikue Ndam N; Nielsen MA
Front Immunol; 2021; 12():634508. PubMed ID: 33717176
[TBL] [Abstract][Full Text] [Related]
17. Dynamics of anti-VAR2CSA immunoglobulin G response in a cohort of senegalese pregnant women.
Tuikue Ndam NG; Salanti A; Le-Hesran JY; Cottrell G; Fievet N; Turner L; Sow S; Dangou JM; Theander T; Deloron P
J Infect Dis; 2006 Mar; 193(5):713-20. PubMed ID: 16453268
[TBL] [Abstract][Full Text] [Related]
18. The case for PfEMP1-based vaccines to protect pregnant women against Plasmodium falciparum malaria.
Hviid L
Expert Rev Vaccines; 2011 Oct; 10(10):1405-14. PubMed ID: 21988306
[TBL] [Abstract][Full Text] [Related]
19. Pregnancy-associated malaria--on the brink?
Craig AG
Trends Parasitol; 2004 May; 20(5):201-4. PubMed ID: 15105015
[No Abstract] [Full Text] [Related]
20. Malaria vaccine: a current perspective.
Sharma S; Pathak S
J Vector Borne Dis; 2008 Mar; 45(1):1-20. PubMed ID: 18399312
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
